Featured Issue Briefs
The Battle on the Home Front: Jonathan Gadsden's Story
Marine Lance Corporal's story reflects the growing need for new antibiotics that can treat dangerous diseases, against which most drugs are useless. Read More
Facilitating Medical Device Innovation: De Novo Reform
The de novo process -- which requests lower-risk reclassification of medical devices and entry into the marketplace -- as it exists now is not achieving its purpose and has instead added unnecessary and time-consuming requirements. Read More
Food Products Recalled by FDA
Since President Obama signed the FDA Food Safety Modernization Act into law, at least 149 FDA-regulated food products have been recalled due to potential pathogenic contamination. Read More
More Issue Briefs
| Date | Issue Briefs | Topic |
|---|---|---|
| Apr 4, 2013 |
Pew Comments on Draft Recommendations for Meaningful Use, Stage 3The Pew Charitable Trusts submitted comments on preliminary recommendations regarding Stage 3 meaningful use objectives and standards for electronic health records (EHRs) to the Office of the National Coordinator for Health Information Technology. These comments follow remarks at recent meetings of the Health Information Technology (HIT) Policy Committee and HIT Standards Committee. More info |
|
| Mar 20, 2013 |
Washington Food Leaders Urge Sen. Murray to Shine a Light on Industrial Farms' Antibiotic UseSixteen of Washington state’s most celebrated chefs, farmers, and other food leaders wrote a letter to Senator Patty Murray, member of the Senate HELP Committee, asking to reauthorize the Animal Drug User Fee Act and include in it provisions to help preserve the efficacy of antibiotics vital to protecting public health. More info |
|
| Mar 15, 2013 |
Groups Urge Obama to Take Action Against Drug-Resistant BacteriaPew and 46 other public health, medical, environmental and consumer leaders urged President Obama to take swifter action to protect the public from drug-resistant bacteria. In a joint letter, they call on his administration to eliminate industrial farms’ non-therapeutic use of medically important antibiotics and to support legislation that requires the Food and Drug Administration to shine more light on farming practices that are breeding superbugs. More info |
|
| Feb 26, 2013 |
Health, Science Leaders Call on Congress for More Antibiotics DataA broad coalition of medical, public health, scientific, agricultural, consumer, environmental and humane organizations, representing more than 11 million supporters, wrote a letter urging Congress to reauthorize the Animal Drug User Fee Act (ADUFA) and include in it provisions to help preserve the efficacy of antibiotics vital to protecting public health. More info |
Antibiotics in Food Animal Production |
| Feb 5, 2013 |
Comments on the Health Information Technology Patient Safety Action and Surveillance PlanIn comments to the Office of the National Coordinator for Health Information Technology (ONC), the American College of Cardiology, Consumers Union, the National Women's Health Network, the National Research Center for Women and Families, the Trust for America's Health, and The Pew Charitable Trusts urge the ONC to promote adoption of the unique device identification (UDI) system for medical devices to improve the safety of medical care. More info |
Drugs and Devices at the FDA |
| Jan 15, 2013 |
Comments on Stage 3 of the the Meaningful Use of Health Information TechnologyIn comments to the Office of the National Coordinator for Health Information Technology (ONC), the American College of Cardiology and The Pew Charitable Trusts urge the ONC to incorporate medical device identifiers developed under the FDA’s unique device identification (UDI) system into both electronic health record (EHR) certification criteria and Stage 3 meaningful use (MU) objectives. More info |
Drugs and Devices at the FDA |
| Nov 29, 2012 |
Letter From Pew and Medtronic to HHS Regarding the Physician Payments Sunshine ActThe Pew Health Group and Medtronic, Inc. file a joint letter to the U.S. Department of Health and Human Services urging implementation of the Physician Payments Sunshine Provision, which will require that manufacturers of drugs, devices,biologics or medical supplies report to the agency payments made to physicians and teaching hospitals. More info |
Medical Safety |
| Nov 21, 2012 |
Pew Comments on Advance Notice of Proposed Rulemaking ''Antimicrobial Animal Drug Sales and Distribution Reporting''The Pew Campaign on Human Health and Industrial Farming submitted a letter to the U.S. Food and Drug Administration, urging the FDA to strengthen regulations pertaining to record-keeping and public reporting of antibiotic use in food animal production. More info |
Antibiotics in Food Animal Production |
| Nov 21, 2012 |
Strengthening Our National System for Medical Device Postmarket SurveillanceThe Medical Device Initiative submitted comments to the U.S. Food and Drug Administration concerning the FDA's National Medical Device Postmarket Surveillance Plan, "Strengthening Our National System for Medical Device Postmarket Surveillance." More info |
Drugs and Devices at the FDA |
| Nov 19, 2012 |
Public Health and Consumer Groups Call for Participation in Antibiotic Use MeetingsOn Nov. 2, 15 public health and consumer organizations sent a joint letter to the FDA requesting to join in discussions to consider how the misuse and overuse of antibiotics in livestock and poultry are significant contributing factors to antibiotic resistance in humans. More info |
Antibiotics in Food Animal Production |
| Nov 8, 2012 |
Pew Comments to the FDA Regarding the Unique Device Identification SystemPew’s Medical Device Initiative, along with the American Heart Association and Trust for America’s Health, submitted comments to the U.S. Food and Drug Administration (FDA) regarding its proposed rule for a unique device identification (UDI) system for medical devices. Once implemented by the FDA and utilized by healthcare providers, the UDI system will be the cornerstone for significant improvements in postmarketing surveillance of medical devices. More info |
Drugs and Devices at the FDA |
| Oct 22, 2012 |
Pew's Comment Letter on FDA’s Advanced Notice of Proposed Rulemaking Regarding Data CollectionOn behalf of The Pew Charitable Trusts (Pew), we are writing to urge the U.S. Food and Drug Administration (FDA) to strengthen regulations pertaining to record-keeping and public reporting of antibiotic use in food animal production. More info |
|
| Sep 12, 2012 |
Written Statement of Record Regarding the Sunshine Act by Dr. Daniel J. Carlat of the Pew Health GroupDr. Daniel Carlat, Director of the Pew Prescription Project, appeared before the U.S. Senate Special Committee on Aging to testify about the importance of implementing the Physician Payments Sunshine Act as quickly as possible. More info |
Drug Manufacturing and Distribution, Conflicts of Interest |
| Aug 31, 2012 |
Save Antibiotics August Newsletter (2012)What's in your Lunchbox? & Senators Call for FDA ActionAIP Generating ActBelow is your August 2012 newsletter from the Pew Campaign on Human Health and Industrial Farming. This edition features a video of Supermoms visiting Capitol Hill, a new report on More info |
Antibiotics in Food Animal Production |
| Aug 28, 2012 |
Members of Congress Write Letter to FDA About Antibiotics in Food Animal ProductionTwelve United States congressmen have penned a letter to the Food and Drug Administration making recommendations on improvements to the FDA's policies on food animal production and the use of antibiotics in industrial farming. More info |
Antibiotics in Food Animal Production |
